title: Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
abstract: Fragile X syndrome (FXS) is a common cause of inherited intellectual disability and a well-characterized form of autism spectrum disorder. As brain-derived neurotrophic factor (BDNF) is implicated in the pathophysiology of FXS we examined the effects of reduced BDNF expression on the behavioral phenotype of an animal model of FXS, Fmr1 knockout (KO) mice, crossed with mice carrying a deletion of one copy of the Bdnf gene (Bdnf(+/-)). Fmr1 KO mice showed age-dependent alterations in hippocampal BDNF expression that declined after the age of 4 months compared to wild-type controls. Mild deficits in water maze learning in Bdnf(+/-) and Fmr1 KO mice were exaggerated and contextual fear learning significantly impaired in double transgenics. Reduced BDNF expression did not alter basal nociceptive responses or central hypersensitivity in Fmr1 KO mice. Paradoxically, the locomotor hyperactivity and deficits in sensorimotor learning and startle responses characteristic of Fmr1 KO mice were ameliorated by reducing BNDF, suggesting changes in simultaneously and in parallel working hippocampus-dependent and striatum-dependent systems. Furthermore, the obesity normally seen in Bdnf(+/-) mice was eliminated by the absence of fragile X mental retardation protein 1 (FMRP). Reduced BDNF decreased the survival of newborn cells in the ventral part of the hippocampus both in the presence and absence of FMRP. Since a short neurite phenotype characteristic of newborn cells lacking FMRP was not found in cells derived from double mutant mice, changes in neuronal maturation likely contributed to the behavioral phenotype. Our results show that the absence of FMRP modifies the diverse effects of BDNF on the FXS phenotype.
authors.affiliation: Institute of Biomedicine, Physiology, University of Helsinki, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Uutela
authors.forename: J
authors.initials: J
authors.lastname: Lindholm
authors.forename: V
authors.initials: V
authors.lastname: Louhivuori
authors.forename: H
authors.initials: H
authors.lastname: Wei
authors.forename: L M
authors.initials: LM
authors.lastname: Louhivuori
authors.forename: A
authors.initials: A
authors.lastname: Pertovaara
authors.forename: K
authors.initials: K
authors.lastname: Akerman
authors.forename: E
authors.initials: E
authors.lastname: Castrén
authors.forename: M L
authors.initials: ML
authors.lastname: Castrén
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics* / Q000378:metabolism; D002478:Cells, Cultured; D003072:Cognition Disorders / Q000235:genetics* / Q000378:metabolism; D003213:Conditioning, Psychological / Q000502:physiology; D005239:Fear / Q000502:physiology; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics* / Q000378:metabolism; D020233:Gait Disorders, Neurologic / Q000235:genetics* / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism; D006948:Hyperkinesis / Q000235:genetics* / Q000378:metabolism; D018782:Maze Learning / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D009043:Motor Activity / Q000235:genetics; D058953:Neural Stem Cells; D009474:Neurons / Q000378:metabolism; D013216:Reflex, Startle / Q000235:genetics
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D051860:Fragile X Messenger Ribonucleoprotein 1; C497684:Fmr1 protein, mouse